<DOC>
	<DOCNO>NCT02614157</DOCNO>
	<brief_summary>Lateral lymph node ( LLD ) metastasis major cause local recurrence advance rectal cancer . As treatment strategy LLN metastasis , huge controversy whether lateral pelvic lymph node dissection ( LLND ) neoadjuvant chemo-radiotherapy ( nCRT ) Western Eastern country . Retrospective cohort evidence indicate LLND follow total mesorectal excision ( TME ) bring benefit cT3-4 rectal cancer , regular predictive LLND , bring side effect contrary . Existing report tend recommend LLND specific individual suspicious LLN metastasis . Moreover , blank strict prospective randomize control study comparison LLND+TME LLND nCRT . Therefore , trial compare efficacy safety two strategy mid/low rectal cancer suspicious LLN metastasis . The risk factor ( radiologic factor , pathologic factor , serum protein ) predict local recurrence overall survival investigate .</brief_summary>
	<brief_title>Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation Advanced Low Rectal Cancer</brief_title>
	<detailed_description>Recently , incidence mortality colorectal cancer increase , lead second prevalence lung cancer . Local recurrence mid/low rectal cancer poor prognostic factor also threat terrible quality life . Although universal usage neoadjuvant chemo-radiotherapy ( nCRT ) total mesorectal excision ( TME ) decrease local recurrence 5 % -10 % , ratio local recurrence occupy almost 30 % total metastasis recurrence incidence , limited therapeutic effect rectal cancer . Increasing evidence demonstrate lateral pelvic lymph node ( LLN ) metastasis one prominent cause local recurrence , accompany 10 % -25 % advanced rectal cancer . Published research also reminder u preoperative LLN involvement may lead high local recurrence poor overall survival . As treatment strategy LLN metastasis , huge controversy whether lateral pelvic lymph node dissection ( LLND ) LLND+TME nCRT : Eastern country especially Japan favor LLND follow TME reason : 1 ) incidence LLN metastasis reach high 10 % -25 % 27 % rectal patient undergo TME solely ( without LLND ) develop local recurrence . And predictive pelvic recurrence rate decrease 50 % ; correspond 5-year overall survival increase 8 % -9 % . 2 ) efficacy LLND equal resection `` local lymph node metastasis '' . A large cohort 11567 case Japan demonstrate resection iliac lymph node metastasis show difference TME cTxN2aM0 resection obturator external iliac lymph node favor liver metastasis . 3 ) Japanese Guidelines treatment colorectal 2014 also recommend mid/low II/III rectal cancer peritoneal reflex undergo regular TME+LLND . On contrary , western country favor sole TME nCRT LLN metastasis , hold : 1 ) rate lymph node metastasis relatively low LLN metastasis regard systemic metastasis . 2 ) LLND experience longer operative time , high postoperative complication , poor quality life . 3 ) American NCCN European ESMO guideline recommend single TME rectal cancer , necessary , LLDN add LLN indeed metastasis . However , blank strict prospective randomize control study comparison nCRT LLND . Present exist retrospective cohort mainly focus mid/low advance cancer , specific individual suspicious LLN metastasis . In fact , result almost indicate difference local recurrence overall survival , except less operation time , blood loss , perioperative complication LLND . Although late research start report preliminary outcome , patient sample size small achieve vary recurrence overall survival . In conclusion , treatment strategy colorectal cancer focus individual precision . Massive retrospective report indicate rectal cancer patient LLN metastasis benefit LLND , however , hot controversy treatment whether TME+LLND TME+nCRT specific rectal patient suspicious LLN metastasis . Therefore , trial compare efficacy safety two strategy mid/low rectal cancer suspicious LLN metastasis . The risk factor ( radiologic factor , pathologic factor , serum protein ) predict local recurrence overall survival investigate .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Histologically confirm rectal cancer ( peritoneal reflection ) Clinical stage I , II , III No extramesorectal lymph node swell ( short diameter less 10 mm ) No invasion organ ( ) PS : 0 , 1 No past history chemotherapy , pelvic surgery radiation Written inform consent operative criterion : Mesorectal excision perform Operative finding : Main lesion tumor locate rectum Lower tumor margin peritoneal reflection R0 resection High rectal cancer Multiple cancer patient Pregnant patient Psychological disorder Steroid administration Cardiac infarction within six month Severe pulmonary emphysema pulmonary fibrosis Doctor 's decision exclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>rectal cancer</keyword>
	<keyword>lateral lymph node dissection</keyword>
	<keyword>neoadjuvant chemoradiation</keyword>
	<keyword>total mesorectal excision</keyword>
	<keyword>surgery</keyword>
	<keyword>recurrence</keyword>
	<keyword>metastasis</keyword>
	<keyword>overall survival</keyword>
</DOC>